Cargando…
Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer in men and a leading cause of cancer-related death. In recent decades, the development of immunotherapies has resulted in great promise to cure metastatic disease. However, prostate cancer has failed to show any significant response, presumably...
Autores principales: | Ollivier, Luc, Labbé, Maureen, Fradin, Delphine, Potiron, Vincent, Supiot, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477651/ https://www.ncbi.nlm.nih.gov/pubmed/34595122 http://dx.doi.org/10.3389/fonc.2021.744679 |
Ejemplares similares
-
microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation
por: Labbé, Maureen, et al.
Publicado: (2020) -
Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
por: Dal Pra, Alan, et al.
Publicado: (2017) -
Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
por: Cailleteau, Axel, et al.
Publicado: (2021) -
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives
por: Detti, Beatrice, et al.
Publicado: (2022) -
Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models
por: Clément-Colmou, Karen, et al.
Publicado: (2020)